![A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay](https://www.oatext.com/img/HMO-4-195-g002.gif)
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
![CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis - Mayo Clinic Proceedings CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis - Mayo Clinic Proceedings](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c05f1054-9500-4052-9df0-10bb0d9d38f9/gr1ab_lrg.jpg)
CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis - Mayo Clinic Proceedings
Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting | PLOS ONE
![PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/92e61d19dc92e499c7b7b01818ac923837d9f518/3-Table3-1.png)
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders
![Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | SpringerLink Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10354-022-00912-7/MediaObjects/10354_2022_912_Fig1_HTML.png)